Mega Genomics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-	30.04	-17.62	79.02	79.1
Depreciation & Amortization	-	14.97	15.12	13.77	13.94
Other Amortization	-	0.16	0.16	0.11	0.09
Loss (Gain) From Sale of Investments	-	0.43	0.17	-0.06	-0.1
Stock-Based Compensation	-	7.29	4.95	-	-
Provision & Write-off of Bad Debts	-	-13.98	25.85	6.17	-0.73
Other Operating Activities	-	-1.62	-29.47	10.13	18.66
Change in Accounts Receivable	-	82.92	-7.05	-79.56	-21.38
Change in Inventory	-	-0.9	-0.22	-0.31	-0.53
Change in Accounts Payable	-	4.78	5.56	2.31	14.88
Change in Other Net Operating Assets	-	39.6	-4.36	-0.94	-1.1
Operating Cash Flow	-	163.68	-6.91	30.63	102.84
Operating Cash Flow Growth	-	-	-	-70.22%	175.91%
Capital Expenditures	-	-35.86	-5.01	-4.16	-1.05
Sale (Purchase) of Intangibles	-	-0.24	-0.18	-0.26	-
Investment in Securities	-	2.34	2.63	2.71	-30.04
Investing Cash Flow	-	-33.75	-2.56	-1.71	-31.09
Long-Term Debt Issued	-	23.56	-	-	-
Long-Term Debt Repaid	-	-9.35	-7.32	-10.59	-14.09
Net Debt Issued (Repaid)	-	14.21	-7.32	-10.59	-14.09
Issuance of Common Stock	-	-	184.16	228.82	100
Repurchase of Common Stock	-	-26	-	-214.14	-
Other Financing Activities	-	-1.12	-18.38	-1.47	-1.85
Financing Cash Flow	-	-12.91	158.46	2.62	84.06
Foreign Exchange Rate Adjustments	-	1.44	11.75	-0.89	-
Net Cash Flow	-	118.46	160.74	30.65	155.8
Free Cash Flow	-	127.83	-11.92	26.47	101.79
Free Cash Flow Growth	-	-	-	-74.00%	177.43%
Free Cash Flow Margin	-	84.49%	-8.18%	11.16%	50.09%
Free Cash Flow Per Share	-	0.60	-0.06	0.21	-
Cash Interest Paid	-	1.12	0.72	0.79	1.85
Cash Income Tax Paid	-	3.9	11.26	10.62	13.09
Levered Free Cash Flow	-	98.11	22.72	-193.51	260
Unlevered Free Cash Flow	-	98.82	23.17	-189.19	270.34
Change in Working Capital	-	126.4	-6.07	-78.5	-8.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.